Stay updated with breaking news from End Results Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RedHill Biopharma Announces New U.S. Patent Covering Talicia for H. pylori Infection Through 2034The patent is directed to the Talicia® formulation and pharmaceutical kits for use in the treatment of H.
Transcenta Announces Orphan Drug Designation Granted to TST001 for Treatment of Gastric and Gastroesophageal Junction News provided by Share this article Share this article SUZHOU, China, July 28, 2021 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a clinical stage global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announces that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to TST001, its anti-Claudin18.2 monoclonal antibody currently in Phase I clinical tr...
Cancer detection biotech BARD1 raising $10 million Share Bell Potter is hitting the streets for early cancer diagnostics company BARD1 Life Sciences this week, running a $12 million capital raise for the business. The capital raise takes the form of a $10 million placement and a $2 million share purchase plan to eligible retail investors. The business has reserved the rights to increase or reduce the the share purchase plan. The offer comes at a 13.9 per cent discount to BARD1’s last close price at $1.55 per share. The business is developing early detection tests for breast and ovarian canc...
A look at the beloved actor's highly treatable but rarely curable disease
LOUISVILLE, Ky.--(BUSINESS WIRE)--Onco360®, the nation’s largest independent Oncology Pharmacy, has been selected by Takeda to be a specialty pharmacy partner for ALUNBRIG® (brigatinib), an oral therapy option for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cel...